Craneware (LON:CRW) Hits New 12-Month High - Here's What Happened

Key Points

• Craneware plc reached a new 52-week high during trading, with shares climbing to GBX 2,580 ($35.22), marking a significant increase from the previous closing price of GBX 2,500 ($34.13).
• Analysts are optimistic about Craneware, with several firms issuing "buy" ratings and setting price targets between GBX 2,850 and GBX 2,900, contributing to an average target price of GBX 2,873.67.
• The company has a market capitalization of £905.61 million and shows promising performance metrics with a PE ratio of 6,017.65 and a quick ratio of 1.00.

Craneware plc (LON:CRW - Get Free Report) shares hit a new 52-week high on Wednesday . The company traded as high as GBX 2,580 ($34.76) and last traded at GBX 2,547 ($34.32), with a volume of 30832 shares changing hands. The stock had previously closed at GBX 2,500 ($33.68).

Wall Street Analysts Forecast Growth

CRW has been the topic of a number of recent research reports. Peel Hunt reiterated a "buy" rating and issued a GBX 2,871 price objective on shares of Craneware in a report on Monday, September 15th. Shore Capital reiterated a "buy" rating and issued a GBX 2,850 price objective on shares of Craneware in a report on Tuesday, September 16th. Finally, Berenberg Bank lifted their price objective on shares of Craneware from GBX 2,800 to GBX 2,900 and gave the company a "buy" rating in a report on Monday, September 15th. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has an average rating of "Buy" and a consensus target price of GBX 2,873.67.

Craneware Stock Performance

The stock has a market capitalization of £842.76 million, a price-to-earnings ratio of 5,600.00 and a beta of 0.28. The company's fifty day simple moving average is GBX 2,295.74 and its 200 day simple moving average is GBX 2,037.93. The company has a quick ratio of 1.00, a current ratio of 0.63 and a debt-to-equity ratio of 12.22.

About Craneware

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.